Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy for Biliary Tract Cancer in 2021.
Sasaki T, Takeda T, Okamoto T, Ozaka M, Sasahira N. Sasaki T, et al. Among authors: takeda t. J Clin Med. 2021 Jul 14;10(14):3108. doi: 10.3390/jcm10143108. J Clin Med. 2021. PMID: 34300274 Free PMC article. Review.
[IPMN and pancreatic cyst as high risk of pancreatic cancer].
Tada M, Takagi K, Kawakubo K, Hakuta R, Ishigaki K, Takeda T, Fujiwara H, Umefune G, Saito K, Saito T, Watanabe T, Akiyama D, Uchino R, Kishikawa T, Takahara N, Takahashi R, Yamamoto K, Hamada T, Mizuno S, Miyabayashi K, Mohri D, Matsubara S, Kogure H, Nakai Y, Yamamoto N, Sasaki T, Sasahira N, Hirano K, Ijichi H, Tateishi K, Isayama H, Koike K. Tada M, et al. Among authors: takeda t. Nihon Shokakibyo Gakkai Zasshi. 2015 Aug;112(8):1474-8. doi: 10.11405/nisshoshi.112.1474. Nihon Shokakibyo Gakkai Zasshi. 2015. PMID: 26250126 Japanese. No abstract available.
No Survival Benefit from the Inhibition of Renin-Angiotensin System in Biliary Tract Cancer.
Nakai Y, Isayama H, Sasaki T, Takahara N, Saito K, Takeda T, Umefune G, Saito T, Takagi K, Watanabe T, Hamada T, Uchino R, Mizuno S, Yamamoto K, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: takeda t. Anticancer Res. 2016 Sep;36(9):4965-70. doi: 10.21873/anticanres.11065. Anticancer Res. 2016. PMID: 27630357
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Noguchi K, Suzuki T, Nakamura T, Sato T, Ishigaki K, Hakuta R, Takeda T, Uchino R, Mizuno S, Kogure H, Tada M, Koike K. Takahara N, et al. Among authors: takeda t. Cancer Chemother Pharmacol. 2017 Dec;80(6):1105-1112. doi: 10.1007/s00280-017-3456-9. Epub 2017 Oct 16. Cancer Chemother Pharmacol. 2017. PMID: 29038848
Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.
Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Oyama H, Kanai S, Suzuki T, Sato T, Hakuta R, Ishigaki K, Takeda T, Saito T, Mizuno S, Kogure H, Tada M, Koike K. Takahara N, et al. Among authors: takeda t. Invest New Drugs. 2018 Dec;36(6):1093-1102. doi: 10.1007/s10637-018-0670-1. Epub 2018 Oct 15. Invest New Drugs. 2018. PMID: 30324343
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Saito K, Isayama H, Nakai Y, Takahara N, Ishigaki K, Takeda T, Hakuta R, Saito T, Uchino R, Kishikawa T, Hamada T, Mizuno S, Sasaki T, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Saito K, et al. Among authors: takeda t. Invest New Drugs. 2019 Apr;37(2):338-344. doi: 10.1007/s10637-018-0691-9. Epub 2018 Nov 9. Invest New Drugs. 2019. PMID: 30411217 Clinical Trial.
3,776 results